The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Introduction of human apolipoprotein E4 “domain interaction” into mouse apolipoprotein E
Open accessAbstract
Human apolipoprotein E4 (apoE4) binds preferentially to lower density lipoproteins, including very low density lipoproteins, and is associated with increased risk of atherosclerosis and neurodegenerative disorders, including Alzheimer's disease. This binding preference is the result of the presence of Arg-112, which causes Arg-61 in the amino-terminal domain to interact with Glu-255 in the carboxyl-terminal domain. ApoE2 and apoE3, which have Cys-112, bind preferentially to high density lipoproteins (HDL) and do not display apoE4 domain interaction. Mouse apoE, like apoE4, contains the equivalent of Arg-112 and Glu-255, but lacks the critical Arg-61 equivalent (it contains Thr-61). Thus, mouse apoE does not display apoE4 domain interaction and, as a result, behaves like human apoE3, including preferential binding to HDL. To assess the potential role of apoE4 domain interaction in atherosclerosis and neurodegeneration, we sought to introduce apoE4 domain interaction into mouse apoE. Replacing Thr-61 in mouse apoE with arginine converted the binding preference from HDL to very low density lipoproteins in vitro , suggesting that apoE4 domain interaction could be introduced into mouse apoE in vivo . Using gene targeting in embryonic stem cells, we created mice expressing Arg-61 apoE. Heterozygous Arg-61/wild-type apoE mice displayed two phenotypes found in human apoE4/E3 heterozygotes: preferential binding to lower density lipoproteins and reduced abundance of Arg-61 apoE in the plasma, reflecting its more rapid catabolism. These findings demonstrate the successful introduction of apoE4 domain interaction into mouse apoE in vivo . The Arg-61 apoE mouse model will allow the effects of apoE4 domain interaction in lipoprotein metabolism, atherosclerosis, and neurodegeneration to be determined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363
Self-citationApolipoprotein E: Structure-Function Relationships
Weisgraber, K. H. (1994) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60642-7 · Cited by 830
Self-citationSullivan, P. M., Mezdour, H., Aratani, Y., Knouff, C., Najib, J., Reddick, R. L., Quarfordt, S. H., & Maeda, N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.29.17972 · Cited by 575
Isoform-specific binding of apolipoprotein E to beta-amyloid.
LaDu, M. J., Falduto, M. T., Manelli, A. M., Reardon, C. A., Getz, G. S., & Frail, D. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31529-6 · Cited by 540
Raber, J., Wong, D., Buttini, M., Orth, M., Bellosta, S., Pitas, R. E., Mahley, R. W., & Mucke, L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10914 · Cited by 364
Abnormal in vivo metabolism of apolipoprotein E4 in humans.
Gregg, R. E., Zech, L. A., Schaefer, E. J., Stark, D., Wilson, D., & Brewer, H. B. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112645 · Cited by 345
Research works printed but not linked: 30
- 10.1016/S0021-9258(18)54825-0 · DOI
- 10.1074/jbc.273.32.20156 · DOI
- 10.1016/S0021-9258(19)83864-4 · DOI
- 10.1016/S0021-9258(19)70201-4 · DOI
- M G Pepe, L K Curtiss J Immunol 136, 3716–3723 (1986). · DOI
- 10.1096/fasebj.10.13.8940294 · DOI · Paper page
- R W Mahley, S C Rall The Metabolic and Molecular Bases of Inherited Disease, eds C R Scriver, A L Beaudet, W S Sly, D Valle, B Childs, K W Kinzler, B Vogelstein (McGraw–Hill, New York) 2, 2835–2862 (2001).
- 10.1073/pnas.92.11.4725 · DOI · Paper page
- 10.1016/S0009-8981(99)00097-2 · DOI · Paper page
- 10.1161/01.ATV.9.3.405 · DOI · Paper page
- 10.1016/S0021-9258(18)68778-2 · DOI · Paper page
- 10.1074/jbc.271.32.19053 · DOI · Paper page
- 10.1016/0378-1119(88)90005-4 · DOI · Paper page
- 10.1093/nar/16.15.7351 · DOI · Paper page
- 10.1016/S0021-9258(18)50713-4 · DOI · Paper page
- 10.1073/pnas.92.5.1774 · DOI · Paper page
- 10.1038/ng0298-136 · DOI · Paper page
- 10.1016/0003-2697(87)90021-2 · DOI · Paper page
- 10.1172/JCI2131 · DOI · Paper page
- G Utermann Diabetes, Obesity and Hyperlipidemias III, eds G Crepaldi, A Tiengo, G Baggio (Elsevier Science, Amsterdam), pp. 1–28 (1985).
- 10.1161/01.ATV.20.7.1807 · DOI
- 10.1172/JCI1847 · DOI · Paper page
- 10.1111/j.1749-6632.1996.tb34431.x · DOI
- 10.1001/jama.1997.03540340052032 · doi:10.1001/jama.1997.03540340052032 · Paper page
- 10.1097/00041433-199906000-00003 · DOI · Paper page
- 10.1016/S0002-9440(10)64963-2 · DOI · Paper page
- 10.1523/JNEUROSCI.19-12-04867.1999 · DOI · Paper page
- 10.1016/S0306-4522(00)00069-5 · DOI
- 10.1093/hmg/9.3.353 · DOI
- 10.1016/S0092-8674(00)00006-4 · DOI
Cited by
Mahley, R. W., Weisgraber, K. H., & Huang, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600549103 · Cited by 912
Self-citationApolipoprotein E structure: insights into function
Hatters, D. M., Peters-Libeu, C. A., & Weisgraber, K. H. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.06.008 · Cited by 583
Self-citationApolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS
Mahley, R. W., Weisgraber, K. H., & Huang, Y. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800069-jlr200 · Cited by 580
Self-citationA Quarter Century of APOE and Alzheimer’s Disease: Progress to Date and the Path Forward
Belloy, M. E., Napolioni, V., & Greicius, M. D. (2019) · Neuron · doi:10.1016/j.neuron.2019.01.056 · Cited by 570
Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism
Mahley, R. W. (2016) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.116.307023 · Cited by 516
Metadata
- Authors
- Raffaï, R. L., Dong, L.-M., Farese, R. V., & Weisgraber, K. H.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2001-09-11
- Volume
- 98
- Issue
- 20
- Pages
- 11587-11591
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2000913322
- Cited by
- 194
- References
- 16
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Introduction of human apolipoprotein E4 “domain interaction” into mouse apolipoprotein E. https://app.cochat.ai/papers/10.1073/pnas.201279298
- The paper
- Raffaï, R. L., Dong, L.-M., Farese, R. V., & Weisgraber, K. H. (2001). Introduction of human apolipoprotein E4 “domain interaction” into mouse apolipoprotein E. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.201279298
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.